OSE Immunotherapeutics Appoints Alexis Vandier as Chief Executive Officer
OSE Immunotherapeutics NANTES, France, July 13, 2022 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) is pleased to [...]
Roche rings Bicycle bell again, grabbing another cancer target
Roche’s Genentech unit has gone all in on its collaboration with UK biotech Bicycle Therapeutics, taking up an option on [...]
Critical Contrast: Prelude Therapeutics (NASDAQ:PRLD) versus Vertex Pharmaceuticals (NASDAQ:VRTX)
Prelude Therapeutics ( NASDAQ:PRLD – Get Rating ) and Vertex Pharmaceuticals ( NASDAQ:VRTX – Get Rating ) are both medical [...]
Abliva AB (OTCMKTS:NEVPF) & KemPharm (NASDAQ:KMPH) Critical Contrast
Abliva AB (publ) ( OTCMKTS:NEVPF – Get Rating ) and KemPharm ( NASDAQ:KMPH – https://report.stocknews.com/sign-up/ticker/?ticker=KMPH&lead_source=marketbeat_snra&utm_source=marketbeat_snra&utm_medium=article&utm_campaign=ticker&utm_term=KMPH&utm_content=text_link ) are both medical companies, [...]
Global Gene Therapy Market to Garner a Revenue of About $6 Billion by 2031
Kenneth Research Key Companies Covered in the Global Gene Therapy Market by Kenneth Research are Kineta, Inc., Novartis AG, Amgen [...]
What can Europeans learn from Canada for the upcoming EU joint HTA, Gabriel Tremblay?
EU joint HTA will become reality in the next few years as communicated recently by the European Commission. However, applicability [...]
Using External Control Arm Studies in HTA Submissions: An Alternative, When RCTs are not Feasible
Matthias Hunger, Céline Taveau, and Ankit Pahwa present the challenges and opportunities when using external control arm studies in submissions to HTA agencies.
NICE Talking to You: The Value of Early Scientific Advice
Starting in 2009, NICE became a pioneer among health technology assessment (HTA) agencies by offering the opportunity for early scientific [...]
Are you in touch with the latest payer thinking?
In the third of her five-part series on digital transformation in market access, Dr. Patti Peeples, CEO of HealthEconomics.com, sits [...]
Payer and HTA submissions: how digital technology is transforming market access processes
In the first of her five-part series on digital transformation in market access, Dr Patti Peeples, CEO of HealthEconomics.com, sits down with Claire Chadwick, HTA Manager at PRMA Consulting.